Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saccharomyces boulardii for prevention of antibiotic-associated diarrhoea
DRKS00000084Phase 3Terminated
- Sponsor
- Bernhard Nocht Institute for Tropical Medicine
- Start
- Apr 2010
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of saccharomyces boulardii in antibiotic-associated diarrhea (AAD), Clostridioides difficile infection (CDI), sponsored by Bernhard Nocht Institute for Tropical Medicine. Started Apr 2010; status: terminated.
02
Drugs
saccharomyces boulardii
03
Conditions
antibiotic-associated diarrhea (AAD)Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on DRKS00000084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000084.